Harte Hanks Financials
This page shows Harte Hanks (HHS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Harte Hanks has an operating margin of 0.2%, meaning the company retains $0 of operating profit per $100 of revenue. This below-average margin results in a low score of 23/100, suggesting thin profitability after operating expenses. This is down from 1.1% the prior year.
Harte Hanks's revenue declined 13.9% year-over-year, from $185.2M to $159.6M. This contraction results in a growth score of 10/100.
Harte Hanks has a moderate D/E ratio of 3.47. This balance of debt and equity financing earns a leverage score of 31/100.
Harte Hanks's current ratio of 1.54 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 26/100, which could limit financial flexibility.
While Harte Hanks generated -$1.7M in operating cash flow, capex of $2.8M consumed most of it, leaving -$4.5M in free cash flow. This results in a low score of 18/100, reflecting heavy capital investment rather than weak cash generation.
Harte Hanks generates a -4.0% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 2/100. This is up from -139.7% the prior year.
Harte Hanks scores 14.51, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Harte Hanks passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Harte Hanks generates $2.14 in operating cash flow (-$1.7M OCF vs -$811K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Harte Hanks generated $159.6M in revenue in fiscal year 2025. This represents a decrease of 13.9% from the prior year.
Harte Hanks's EBITDA was $4.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 25.0% from the prior year.
Harte Hanks reported -$811K in net income in fiscal year 2025. This represents an increase of 97.3% from the prior year.
Harte Hanks earned $-0.11 per diluted share (EPS) in fiscal year 2025. This represents an increase of 97.3% from the prior year.
Cash & Balance Sheet
Harte Hanks generated -$4.5M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 33.3% from the prior year.
Harte Hanks held $5.6M in cash against $0 in long-term debt as of fiscal year 2025.
Harte Hanks had 7M shares outstanding in fiscal year 2025. This represents an increase of 0.8% from the prior year.
Margins & Returns
Harte Hanks's operating margin was 0.2% in fiscal year 2025, reflecting core business profitability. This is down 0.9 percentage points from the prior year.
Harte Hanks's net profit margin was -0.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 15.8 percentage points from the prior year.
Harte Hanks's ROE was -4.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 135.7 percentage points from the prior year.
Capital Allocation
Harte Hanks invested $2.8M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 26.4% from the prior year.
HHS Income Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $39.9M+0.9% | $39.5M+2.3% | $38.6M-7.0% | $41.6M-11.8% | $47.1M-1.1% | $47.6M+5.8% | $45.0M-0.9% | $45.4M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $5.7M+10.3% | $5.1M-7.0% | $5.5M-5.2% | $5.8M+2.0% | $5.7M+8.9% | $5.3M-10.1% | $5.9M-1.5% | $5.9M |
| Operating Income | -$117K-123.0% | $509K+1397.1% | $34K+185.0% | -$40K+97.4% | -$1.6M-181.8% | $1.9M+38.2% | $1.4M+266.1% | $375K |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$11K |
| Income Tax | -$2.5M-196.3% | $2.6M+3439.7% | -$78K+63.7% | -$215K-137.7% | $570K-34.3% | $868K+109.6% | -$9.0M-12581.7% | -$71K |
| Net Income | $2.2M+196.3% | -$2.3M-582.4% | -$335K+14.5% | -$392K+83.9% | -$2.4M-1814.1% | $142K+100.5% | -$27.8M-16177.2% | -$171K |
| EPS (Diluted) | N/A | $-0.31-520.0% | $-0.050.0% | $-0.05 | N/A | $0.02+100.5% | $-3.84-19100.0% | $-0.02 |
HHS Balance Sheet
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $91.8M-1.0% | $92.7M-2.4% | $95.0M-5.5% | $100.6M-1.2% | $101.8M-5.9% | $108.1M-1.5% | $109.7M-3.3% | $113.4M |
| Current Assets | $46.3M-4.9% | $48.7M-2.6% | $50.0M-6.9% | $53.7M+0.2% | $53.6M-0.4% | $53.8M-2.2% | $55.0M-4.7% | $57.8M |
| Cash & Equivalents | $5.6M-14.3% | $6.5M+36.9% | $4.8M-47.0% | $9.0M-8.4% | $9.8M+65.0% | $5.9M-45.8% | $11.0M-4.3% | $11.5M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $27.8M-7.8% | $30.2M-12.2% | $34.4M+16.3% | $29.6M-6.5% | $31.6M-4.9% | $33.3M+8.9% | $30.6M-6.8% | $32.8M |
| Goodwill | $295K0.0% | $295K0.0% | $295K0.0% | $295K0.0% | $295K-84.7% | $1.9M0.0% | $1.9M0.0% | $1.9M |
| Total Liabilities | $71.3M-2.1% | $72.8M+0.1% | $72.8M-8.1% | $79.2M-1.2% | $80.1M-8.0% | $87.1M-2.3% | $89.1M-4.7% | $93.5M |
| Current Liabilities | $30.2M-8.6% | $33.0M+5.7% | $31.2M-13.5% | $36.1M+2.7% | $35.1M-4.9% | $36.9M+1.5% | $36.4M-9.3% | $40.2M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $20.5M+3.2% | $19.9M-10.6% | $22.2M+3.8% | $21.4M-1.2% | $21.7M+3.0% | $21.0M+2.1% | $20.6M+3.2% | $20.0M |
| Retained Earnings | $813.8M+0.3% | $811.6M-0.3% | $813.9M0.0% | $814.2M0.0% | $814.6M-0.3% | $817.1M0.0% | $816.9M-3.3% | $844.7M |
HHS Cash Flow Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $737K-76.9% | $3.2M+165.9% | -$4.8M-492.9% | -$818K-120.2% | $4.0M+237.2% | -$2.9M-283.3% | $1.6M+128.3% | -$5.7M |
| Capital Expenditures | $1.4M+41.5% | $1.0M+351.1% | $223K+112.4% | $105K-83.3% | $627K-67.2% | $1.9M+180.2% | $682K+29.7% | $526K |
| Free Cash Flow | -$686K-131.3% | $2.2M+143.2% | -$5.1M-449.6% | -$923K-127.0% | $3.4M+170.3% | -$4.9M-624.7% | $926K+114.9% | -$6.2M |
| Investing Cash Flow | -$1.4M-41.4% | -$1.0M-347.1% | -$225K-118.4% | -$103K+83.5% | -$626K+67.2% | -$1.9M-180.2% | -$682K-29.9% | -$525K |
| Financing Cash Flow | -$41K+73.5% | -$155K-119.9% | $778K+1244.1% | -$68K+27.7% | -$94K+42.3% | -$163K-1153.8% | -$13K+91.3% | -$149K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | $0 | $0 | N/A | N/A |
HHS Financial Ratios
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | -0.3%-1.6pp | 1.3%+1.2pp | 0.1%+0.2pp | -0.1%+3.2pp | -3.3%-7.3pp | 4.0%+0.9pp | 3.0%+2.2pp | 0.8% |
| Net Margin | 5.5%+11.3pp | -5.8%-4.9pp | -0.9%+0.1pp | -0.9%+4.2pp | -5.2%-5.5pp | 0.3%+62.1pp | -61.8%-61.4pp | -0.4% |
| Return on Equity | 10.7%+22.2pp | -11.5%-10.0pp | -1.5%+0.3pp | -1.8%+9.4pp | -11.2%-11.9pp | 0.7%+135.7pp | -135.1%-134.2pp | -0.9% |
| Return on Assets | 2.4%+4.9pp | -2.5%-2.1pp | -0.4%+0.0pp | -0.4%+2.0pp | -2.4%-2.5pp | 0.1%+25.5pp | -25.4%-25.2pp | -0.1% |
| Current Ratio | 1.54+0.1 | 1.48-0.1 | 1.60+0.1 | 1.49-0.0 | 1.53+0.1 | 1.46-0.1 | 1.51+0.1 | 1.44 |
| Debt-to-Equity | 3.47-0.2 | 3.66+0.4 | 3.27-0.4 | 3.700.0 | 3.69-0.4 | 4.14-0.2 | 4.32-0.4 | 4.68 |
| FCF Margin | -1.7%-7.3pp | 5.5%+18.7pp | -13.1%-10.9pp | -2.2%-9.5pp | 7.2%+17.4pp | -10.2%-12.3pp | 2.1%+15.7pp | -13.7% |
Similar Companies
Frequently Asked Questions
What is Harte Hanks's annual revenue?
Harte Hanks (HHS) reported $159.6M in total revenue for fiscal year 2025. This represents a -13.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Harte Hanks's revenue growing?
Harte Hanks (HHS) revenue declined by 13.9% year-over-year, from $185.2M to $159.6M in fiscal year 2025.
Is Harte Hanks profitable?
No, Harte Hanks (HHS) reported a net income of -$811K in fiscal year 2025, with a net profit margin of -0.5%.
What is Harte Hanks's EBITDA?
Harte Hanks (HHS) had EBITDA of $4.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Harte Hanks's operating margin?
Harte Hanks (HHS) had an operating margin of 0.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Harte Hanks's net profit margin?
Harte Hanks (HHS) had a net profit margin of -0.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Harte Hanks's return on equity (ROE)?
Harte Hanks (HHS) has a return on equity of -4.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Harte Hanks's free cash flow?
Harte Hanks (HHS) generated -$4.5M in free cash flow during fiscal year 2025. This represents a 33.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Harte Hanks's operating cash flow?
Harte Hanks (HHS) generated -$1.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Harte Hanks's total assets?
Harte Hanks (HHS) had $91.8M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Harte Hanks's capital expenditures?
Harte Hanks (HHS) invested $2.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Harte Hanks's current ratio?
Harte Hanks (HHS) had a current ratio of 1.54 as of fiscal year 2025, which is generally considered healthy.
What is Harte Hanks's debt-to-equity ratio?
Harte Hanks (HHS) had a debt-to-equity ratio of 3.47 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Harte Hanks's return on assets (ROA)?
Harte Hanks (HHS) had a return on assets of -0.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Harte Hanks's cash runway?
Based on fiscal year 2025 data, Harte Hanks (HHS) had $5.6M in cash against an annual operating cash burn of $1.7M. This gives an estimated cash runway of approximately 39 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Harte Hanks's Altman Z-Score?
Harte Hanks (HHS) has an Altman Z-Score of 14.51, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Harte Hanks's Piotroski F-Score?
Harte Hanks (HHS) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Harte Hanks's earnings high quality?
Harte Hanks (HHS) has an earnings quality ratio of 2.14x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Harte Hanks?
Harte Hanks (HHS) scores 18 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.